We are live on ! Find out more
FEED

ENvue Medical Inc

14 hedge funds and large institutions have $593K invested in ENvue Medical Inc in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

8% more funds holding

Funds holding: 1314 (+1)

0% more ownership

Funds ownership: 0%0% (+0%)

13% less capital invested

Capital invested by funds: $679K → $593K (-$86K)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
1
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change

FEED Hedge Fund Activity: Q4 2022 in Review

14 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in ENvue Medical Inc (FEED) for Q4 2022, worth a combined $593K — down 13% from $679K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new FEED positions and 3 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.

The largest buyer was AWM Investment Company, opening a new position worth an estimated $338K. The largest seller was Susquehanna International Group, cutting an estimated $28K.

  • 14 institutional investors held ENvue Medical Inc (FEED) as of Q4 2022, up from 13 in Q3 2022.
  • Funds reported $593K of ENvue Medical Inc stock for Q4 2022, down 13% quarter-over-quarter.
  • 4 funds opened new ENvue Medical Inc positions in Q4 2022 and 3 closed out, a net change of +1 holder.
  • The largest ENvue Medical Inc buyer in Q4 2022 was AWM Investment Company, an estimated $338K added.
  • The largest ENvue Medical Inc seller in Q4 2022 was Susquehanna International Group, an estimated $28K sold.

Based on aggregated 13F filings for Q4 2022.